// App-Quantinova.ai

P918 : HIGH RESPONSES RATES WITH SINGLE AGENT BELANTAMAB MAFODOTIN IN RELAPSED SYSTEMIC AL AMYLOIDOSIS

Researchers

Presenter

  • Jahanzaib Khwaja

Principal Investigators

  • Shameem Mahmood

  • Brendan Wisniowski

  • Raakhee Shah

  • Anish Tailor

  • Kwee Yong

  • Rakesh Popat

  • Neil Rabin

  • Charalampia Kyriakou

  • Jonathan Sive

  • Sarah Worthington

  • Alyse Hart

  • Emma Dowling

  • Nuno Correia

  • Ceri Bygrave

  • Andrzej Rydzewski

  • Krzysztof Jamroziak

  • Ashutosh Wechalekar

Medical Centers

  • Department of Rheumatology, University College London, London, UK

  • Department of Internal Medicine, Nephrology and Transplantation Medicine,Central Clinical Hospital of

  • Department of Rheumatology, University College London, London, UK

  • Dept. of Haematology, University Hospital of Wales, Cardiff, United Kingdom

  • National Amyloidosis Centre, University College London, London, United Kingdom

  • Department of Internal Medicine, Nephrology and Transplantation Medicine,Central Clinical Hospital of the Ministry of Internal Affairs,Warsaw,Polen

  • Department of Hematology, Transplantation and Internal Medicine,Medical Univer

  • Department of Haematology,Cardiff University, University Hospital of Wales,Cardiff,Vereinigtes Königreich

  • Dept. Haematology,University College London Hospitals,London,Vereinigtes Königreich

  • Department of Haematology,Cardiff University, University Hospital of Wales,Cardiff,Vereinigtes Königreich

  • National Amyloidosis Centre,University College London (Royal Free Campus),London,Royaume-uni

  • Department of Internal Medicine, Nephrology and Transplantation Medicine,Central Clinical Hospital of the Ministry of Internal Affairs,Warsaw,Polen

  • Department I

  • National Amylo

  • Department of Haematology,University Hospital of Wales,Cardiff,Reino Unido

  • Department of Haematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

  • National Amyloidosis Centre,University College London,London,Vereinigtes Königreich

  • Department of Haematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

  • Hematology,University College London Hospitals,London,Royaume-uni

  • Department of Haematology,Cardiff University, University Hospital of Wales,Cardiff,Vereinigtes Königreich

  • Department of Haematological Medicine, King's College London, London, United Kingdom

  • National Amyloidosis Centre,University College London (Royal Free Campus),London,Regno Unito

  • Department of Haematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

Locations

  • United Kingdom

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • AL Amyloidosis

Biomarkers

  • N/A

Drug/Treatment

  • GSK2857916

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT04617925

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved